BioPharmaceutical Emerging Best Practices Association (BEBPA)
We aim to foster publication of white papers and industry surveys which identify current practices, current technical hurdles and potential solutions relevant to the biopharmaceutical community – companies, regulators, clinicians. Identifying emerging issues early during deveopment can often foster quicker and more efficient development for all firms.Learn More
Smaller conferences will be held on various topics and a non-consensus white paper will be published delineating various approaches to solving these problems. The papers are not intended to be guidance documents, but rather strive to present the scientific community with a variety of approaches to potentially solve a common problem. Since the papers are not consensus documents, nor prescribe a preferred approach, publication can occur rapidly in open access journals and publicly available web pages and thus be part of the scientific discussion. Additionally, it is hoped that with the publication of potentially problem-solving approaches, the biopharmaceutical scientific community will accelerate the rate at which a future consensus best practice can be established.
2014 BEBPA Bioassay Brochure